When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Fluticasone furoate/umeclidinium bromide/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate/...

   The combination fluticasone furoate/umeclidinium bromide/vilanterol product is approved by the US Food and Drug Administration with an indication for the maintenance treatment of a chronic lung problem called chronic obstructive pulmonary disease (COPD) in adults who (1) have already tried fluticasone furoate/vilanterol (brand name Breo Ellipta) but are still experiencing symptoms of airway ...

3. Umeclidinium bromide/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Umeclidinium_bromide/...

   The most common side effects include upper respiratory tract infections, urinary tract infections, pharyngitis, sinusitis, nasopharyngitis, headache, cough, oropharyngeal pain, constipation and dry mouth. [4] In 2022, it was the 211th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [7] [8]

4. Fluticasone furoate/vilanterol - Wikipedia

   en.wikipedia.org/wiki/Fluticasone_furoate/vilanterol

   Fluticasone furoate/vilanterol, sold under the brand name Breo Ellipta among others, is a combination medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. [3] It contains fluticasone furoate, an inhaled corticosteroid, and vilanterol, an ultra-long-acting β 2 agonist (ultra-LABA). [3]

5. Ipratropium bromide/salbutamol - Wikipedia

   en.wikipedia.org/wiki/Ipratropium_bromide/salbutamol

   Ipratropium bromide/salbutamol, sold under the brand name Combivent among others, is a combination medication used to treat chronic obstructive pulmonary disease (COPD). [1] [4] [5] It contains ipratropium (an anticholinergic) and salbutamol (albuterol, a β 2-adrenergic agonist). [1] Common side effects include sore throat, muscle cramps, and ...

6. Budesonide/glycopyrronium bromide/formoterol - Wikipedia

   en.wikipedia.org/wiki/Budesonide/glycopyrronium...

   Budesonide/glycopyrronium bromide/formoterol, sold under the brand name Breztri Aerosphere among others, is an inhalable fixed-dose combination medication for the treatment of chronic obstructive pulmonary disease (COPD). [5] [6] [7] It contains budesonide, glycopyrronium bromide, and formoterol fumarate dihydrate. [5] [6] [7] It is inhaled. [5 ...

7. FDA approves new COPD drug developed by firm in Raleigh ... - AOL

   www.aol.com/news/fda-approves-copd-drug...

   A new drug developed by a company with US headquarters in Raleigh, Ohtuvayre, was approved by the FDA Wednesday to help COPD patients manage symptoms.